Lipid metabolism during pregnancy and its implications for fetal growth

Current Pharmaceutical Biotechnology

Volumn 15, Issue 1, 2014, Pages 24-31

  Herrera, Emilio ^a   Ortega Senovilla, Henar ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

Adipocytokines; Adipose tissue; Gestational diabetes mellitus; Hyperlipidemia; Intrauterine growth restriction; Nonesterified fatty acids; Placenta; Pregnancy

Indexed keywords

ESSENTIAL FATTY ACID; FATTY ACID BINDING PROTEIN 4; LIPOPROTEIN LIPASE; POLYUNSATURATED FATTY ACID; RETINOL BINDING PROTEIN 4; TRIACYLGLYCEROL;

ARTICLE; FETUS GROWTH; GLUCONEOGENESIS; GLUCOSE METABOLISM; HUMAN; HYPERINSULINEMIA; HYPERLIPIDEMIA; LIPID METABOLISM; OBESITY; PLACENTAL TRANSFER; PREGNANCY; PREGNANCY DIABETES MELLITUS; SIGNAL TRANSDUCTION; TISSUE METABOLISM; ANIMAL; FEMALE; FETUS DEVELOPMENT; INTRAUTERINE GROWTH RETARDATION; METABOLISM; PREGNANCY COMPLICATION;

ANIMALS; DIABETES, GESTATIONAL; FEMALE; FETAL DEVELOPMENT; FETAL GROWTH RETARDATION; HUMANS; LIPID METABOLISM; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84904751569     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201015666140330192345     Document Type: Article

References (102)

1. Ong, K. K.; Diderholm, B.; Salzano, G.; Wingate, D.; Hughes, I. A.; MacDougall, J.; Acerini, C. L.; Dunger, D. B. Pregnancy insulin, glucose, and BMI contribute to birth outcomes in nondiabetic mothers. Diabet. Care, 2008, 31(11), 2193-2197.
2. Sermer, M.; Naylor, C. D.; Gare, D. J.; Kenshole, A. B.; Ritchie, J. W.; Farine, D.; Cohen, H. R.; McArthur, K.; Holzapfel, S.; Biringer, A. Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. The Toronto Tri-Hospital Gestational Diabetes Project. Am. J. Obstet. Gynecol., 1995, 173(1), 146-156.
3. Pedersen, J. Glucose content of the amniotic fluid in diabetic pregnancies; correlations with the maternal blood sugar. Acta. Endocrinol., 1954, 15(4), 342-354.
4. Sameshima, H.; Kamitomo, M.; Kajiya, S.; Kai, M.; Furukawa, S.; Ikenoue, S. Early glycemic control reduces large-for-gestationalage infants in 250 Japanese gestational diabetes pregnancies. Am. J. Perinatol., 2000, 17(7), 371-376.
5. Jimenez-Moleon, J. J.; Bueno-Cavanillas, A.; Luna-del-Castillo Jde, D.; Garcia-Martin, M.; Lardelli-Claret, P.; Galvez-Vargas, R. Impact of different levels of carbohydrate intolerance on neonatal outcomes classically associated with gestational diabetes mellitus. Eur. J. Obstet. Gynecol. Reprod. Biol., 2002, 102(1), 36-41.
6. Schwartz, R.; Gruppuso, P. A.; Petzold, K.; Brambilla, D.; Hiilesmaa, V.; Teramo, K. A. Hyperinsulinemia and macrosomia in the fetus of the diabetic mother. Diabet. Care, 1994, 17(7), 640-648.
7. Ortega-Senovilla, H.; Schaefer-Graf, U.; Meitzner, K.; Abou-Dakn, M.; Herrera, E. Decreased concentrations of the lipoprotein lipase inhibitor angiopoietin-like protein 4 and increased serum triacylglycerol are associated with increased neonatal fat mass in pregnant women with gestational diabetes mellitus. J. Clin. Endocrinol. Metab., 2013, 98(8), 3430-3437.
8. Evers, I. M.; de Valk, H. W.; Mol, B. W.; ter Braak, E. W.; Visser, G. H. Macrosomia despite good glycaemic control in Type I diabetic pregnancy; results of a nationwide study in The Netherlands. Diabetologia, 2002, 45(11), 1484-1489.
9. Herrera, E.; Lasunción, M. A. Maternal-fetal transfer of lipid metabolites. In Fetal and Neonatal Physiology, Polin, R. A.; Fox, W. F. and Steven, H. A., Eds.; Elsevier Saunders: Philadelphia, USA, 2011, pp. 441-454.
10. Kitajima, M.; Oka, S.; Yasuhi, I.; Fukuda, M.; Rii, Y.; Ishimaru, T. Maternal serum triglyceride at 24--32 weeks' gestation and newborn weight in nondiabetic women with positive diabetic screens. Obstet. Gynecol., 2001, 97(5 Pt 1), 776-780.
11. Nolan, C. J.; Riley, S. F.; Sheedy, M. T.; Walstab, J. E.; Beischer, N. A. Maternal serum triglyceride, glucose tolerance, and neonatal birth weight ratio in pregnancy. Diabet. Care, 1995, 18(12), 1550-1556.
12. Schaefer-Graf, U. M.; Graf, K.; Kulbacka, I.; Kjos, S. L.; Dudenhausen, J.; Vetter, K.; Herrera, E. Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabet. Care, 2008, 31(9), 1858-1863.
13. Herrera, E.; Ortega-Senovilla, H. Disturbances in lipid metabolism in diabetic pregnancy-Are these the cause of the problem? Best Pract. Res. Clin. Endocrinol. Metab., 2010, 24(4), 515-525.
14. Alvarez, J. J.; Montelongo, A.; Iglesias, A.; Lasuncion, M. A.; Herrera, E. Longitudinal study on lipoprotein profile, high density lipoprotein subclass, and postheparin lipases during gestation in women. J. Lipid Res., 1996, 37(2), 299-308.
15. Montelongo, A.; Lasuncion, M. A.; Pallardo, L. F.; Herrera, E. Longitudinal study of plasma lipoproteins and hormones during pregnancy in normal and diabetic women. Diabetes, 1992, 41(12), 1651-1659.
16. Hay, W. W., Jr. Placental-fetal glucose exchange and fetal glucose metabolism. Trans. Am. Clin. Climatol. Assoc., 2006, 117, 321-339.
17. Ortega-Senovilla, H.; Schaefer-Graf, U.; Meitzner, K.; Abou-Dakn, M.; Graf, K.; Kintscher, U.; Herrera, E. Gestational diabetes mellitus causes changes in the concentrations of adipocyte fatty acid-binding protein and other adipocytokines in cord blood. Diabet. Care, 2011, 34(4), 2061-2066.
18. Schaefer-Graf, U. M.; Meitzner, K.; Ortega-Senovilla, H.; Graf, K.; Vetter, K.; Abou-Dakn, M.; Herrera, E. Differences in the implications of maternal lipids on fetal metabolism and growth between gestational diabetes mellitus and control pregnancies. Diabet. Med., 2011, 28(9), 1053-1059.
19. Malassine, A.; Frendo, J. L.; Evain-Brion, D. A comparison of placental development and endocrine functions between the human and mouse model. Hum Reprod Update, 2003, 9(6), 531-539.
20. Carter, A. M. Animal models of human placentation--a review. Placenta, 2007, 28(Suppl A), S41-47.
21. Lim, H. J.; Wang, H. Uterine disorders and pregnancy complications: insights from mouse models. J. Clin. Invest., 2010, 120(4), 1004-1015.
22. Lopez-Luna, P.; Maier, I.; Herrera, E. Carcass and tissue fat content in the pregnant rat. Biol. Neonate, 1991, 60(1), 29-38.
23. Hytten, F. E. Component of weight gain. I. The product for conception. In The physiology of human pregnancy, Hytten, F. E. and Leitch, I., Eds.; Blackwell Scientific Publications: Oxford, 1971, pp. 286-369.
24. Murphy, S. P.; Abrams, B. F. Changes in energy intakes during pregnancy and lactation in a national sample of US women. Am. J. Public Health, 1993, 83(8), 1161-1163.
25. Jovanovic, L.; Metzger, B. E.; Knopp, R. H.; Conley, M. R.; Park, E.; Lee, Y. J.; Simpson, J. L.; Holmes, L.; Aarons, J. H.; Mills, J. L. The Diabetes in Early Pregnancy Study: beta-hydroxybutyrate levels in type 1 diabetic pregnancy compared with normal pregnancy. NICHD-Diabetes in Early Pregnancy Study Group (DIEP). National Institute of Child Health and Development. Diabet. Care, 1998, 21(11), 1978-1984.
26. Buch, I.; Hornnes, P. J.; Kuhl, C. Glucose tolerance in early pregnancy. Acta Endocrinol., 1986, 112(2), 263-266.
27. Ramos, M. P.; Crespo-Solans, M. D.; del Campo, S.; Cacho, J.; Herrera, E. Fat accumulation in the rat during early pregnancy is modulated by enhanced insulin responsiveness. Am. J. Physiol. Endocrinol. Metab., 2003, 285(2), E318-E328.
28. Palacin, M.; Lasuncion, M. A.; Asuncion, M.; Herrera, E. Circulating metabolite utilization by periuterine adipose tissue in situ in the pregnant rat. Metabolism, 1991, 40(5), 534-539.
29. Knopp, R. H.; Boroush, M. A.; O'Sullivan, J. B. Lipid metabolism in pregnancy. II. Postheparin lipolytic acitivity and hypertriglyceridemia in the pregnant rat. Metabolism, 1975, 24(4), 481-493.
30. Lasuncion, M. A.; Herrera, E. Changes with starvation in the rat of the lipoprotein lipase activity and hydrolysis of triacylglycerols from triacylglycerol-rich lipoproteins in adipose tissue preparations. Biochem. J., 1983, 210(3), 639-643.
31. Herrera, E.; Lasuncion, M. A.; Gomez-Coronado, D.; Aranda, P.; Lopez-Luna, P.; Maier, I. Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy. Am. J. Obstet. Gynecol., 1988, 158(6 Pt 2), 1575-1583.
32. Knopp, R. H.; Herrera, E.; Freinkel, N. Carbohydrate metabolism in pregnancy. 8. Metabolism of adipose tissue isolated from fed and fasted pregnant rats during late gestation. J. Clin. Invest., 1970, 49(7), 1438-1446.
33. Puavilai, G.; Drobny, E. C.; Domont, L. A.; Baumann, G. Insulin receptors and insulin resistance in human pregnancy: Evidence for a postreceptor defect in insulin action. J. Clin. Endocrinol. Metab., 1982, 54(2), 247-253.
34. Stanley, K.; Fraser, R.; Bruce, C. Physiological changes in insulin resistance in human pregnancy: Longitudinal study with the hyperinsulinaemic euglycaemic clamp technique. Br. J. Obstet. Gynaecol., 1998, 105(7), 756-759.
35. Muñoz, C.; Lopez-Luna, P.; Herrera, E. Glucose and insulin tolerance tests in the rat on different days of gestation. Biol. Neonate, 1995, 68(4), 282-291.
36. Ramos, P.; Herrera, E. Reversion of insulin resistance in the rat during late pregnancy by 72-h glucose infusion. Am. J. Physiol., 1995, 269(5 Pt 1), E858-863.
37. Herrera, E.; del Campo, S.; Marciniak, J.; Sevillano, J.; Ramos, M. P. Enhanced utilization of glycerol for glyceride synthesis in isolated adipocytes from early pregnant rats. J. Physiol. Biochem., 2010, 66(3), 245-253.
38. Freinkel, N. Banting Lecture 1980. Of pregnancy and progeny. Diabetes, 1980, 29(12), 1023-1035.
39. Herrera, E.; Knopp, R. H.; Freinkel, N. Urinary excretion of epinephrine and norepinephrine during fasting in late pregnancy in the rat. Endocrinology, 1969, 84(2), 447-450.
40. Sivan, E.; Boden, G. Free fatty acids, insulin resistance, and pregnancy. Curr. Diab. Rep., 2003, 3(4), 319-322.
41. Mampel, T.; Camprodon, R.; Solsona, J.; Junca, V.; Herrera, E. Changes in circulating glycerol, free fatty acids and glucose levels following liver transplant in the pig. Arch. Int. Physiol. Biochim., 1981, 89(3), 195-199.
42. Zorzano, A.; Lasuncion, M. A.; Herrera, E. Role of the availability of substrates on hepatic and renal gluconeogenesis in the fasted late pregnant rat. Metabolism, 1986, 35(4), 297-303.
43. Herrera, E.; Knopp, R. H.; Freinkel, N. Carbohydrate metabolism in pregnancy. VI. Plasma fuels, insulin, liver composition, gluconeogenesis, and nitrogen metabolism during late gestation in the fed and fasted rat. J. Clin. Invest., 1969, 48(12), 2260-2272.
44. Shambaugh, G. E.; Metzger, B. E.; Radosevich, J. A. Nutrient mettabolism and fetal brain development. In Perinatal Biochemistry, Herrera, E. and Knopp, R. H., Eds.; CRC Press: Boca Raton, Florida, USA, 1992, pp. 213-231.
45. Hay, W. W., Jr. Regulation of placental metabolism by glucose supply. Reprod. Fertil. Dev., 1995, 7(3), 365-375.
46. Lasuncion, M. A.; Lorenzo, J.; Palacin, M.; Herrera, E. Maternal factors modulating nutrient transfer to fetus. Biol. Neonate, 1987, 51(2), 86-93.
47. Aldoretta, P. W.; Carver, T. D.; Hay, W. W., Jr. Ovine uteroplacental glucose and oxygen metabolism in relation to chronic changes in maternal and fetal glucose concentrations. Placenta, 1994, 15(7), 753-764.
48. Knopp, R. H.; Ruder, H. J.; Herrera, E.; Freinkel, N. Carbohydrate metabolism in pregnancy. VII. Insulin tolerance during late pregnancy in the fed and fasted rat. Acta. Endocrinol., 1970, 65(2), 352-360.
49. Kuhl, C. Insulin secretion and insulin resistance in pregnancy and GDM. Implications for diagnosis and management. Diabetes, 1991, 40(Suppl 2), 18-24.
50. Knopp, R. H.; Bonet, B.; Lasuncion, M. A.; Herrera, E. Lipoprotein metabolism in pregnancy. In Perinatal biochemistry, Herrera, E. K., R. H., Eds.; CRC Press: Boca Raton, 1992, pp. 19-51.
51. Knopp, R. H.; Zhu, X. Multiple beneficial effects of estrogen on lipoprotein metabolism. J. Clin. Endocrinol. Metab., 1997, 82(12), 3952-3954.
52. Martin-Hidalgo, A.; Holm, C.; Belfrage, P.; Schotz, M. C.; Herrera, E. Lipoprotein lipase and hormone-sensitive lipase activity and mRNA in rat adipose tissue during pregnancy. Am. J. Physiol., 1994, 266(6 Pt 1), E930-935.
53. Iglesias, A.; Montelongo, A.; Herrera, E.; Lasuncion, M. A. Changes in cholesteryl ester transfer protein activity during normal gestation and postpartum. Clin. Biochem., 1994, 27(1), 63-68.
54. Herrera, E. Lipid metabolism in pregnancy and its consequences in the fetus and newborn. Endocrine, 2002, 19(1), 43-55.
55. Herrera, E.; Amusquivar, E.; López-Soldado, I.; Ortega, H. Maternal lipid metabolism and placental lipid transfer. Horm. Res., 2006, 65(3), 59-64.
56. Dutta-Roy, A. K. Transport mechanisms for long-chain polyunsaturated fatty acids in the human placenta. Am. J. Clin. Nutr., 2000, 71(1 Suppl), 315S-322S.
57. Jones, H. N.; Powell, T. L.; Jansson, T. Regulation of placental nutrient transport. A review. Placenta, 2007, 28(8-9), 763-774.
58. Koletzko, B.; Larque, E.; Demmelmair, H. Placental transfer of long-chain polyunsaturated fatty acids (LC-PUFA). J. Perinat. Med., 2007, 35(Suppl 1), S5-S11.
59. Varastehpour, A.; Radaelli, T.; Minium, J.; Ortega, H.; Herrera, E.; Catalano, P.; Hauguel-de Mouzon, S. Activation of phospholipase A2 is associated with generation of placental lipid signals and fetal obesity. J. Clin. Endocrinol. Metab., 2006, 91(1), 248-255.
60. Dekker, G. A.; Sibai, B. M. Etiology and pathogenesis of preeclampsia: Current concepts. Am J Obstet Gynecol, 1998, 179(5), 1359-1375.
61. Enzi, G.; Zanardo, V.; Caretta, F.; Inelmen, E. M.; Rubaltelli, F. Intrauterine growth and adipose tissue development. Am. J. Clin. Nutr., 1981, 34(9), 1785-1790.
62. Cetin, I.; Giovannini, N.; Alvino, G.; Agostoni, C.; Riva, E.; Giovannini, M.; Pardi, G. Intrauterine growth restriction is associated with changes in polyunsaturated fatty acid fetal-maternal relationships. Pediatr. Res., 2002, 52(5), 750-755.
63. Gauster, M.; Hiden, U.; Blaschitz, A.; Frank, S.; Lang, U.; Alvino, G.; Cetin, I.; Desoye, G.; Wadsack, C. Dysregulation of placental endothelial lipase and lipoprotein lipase in intrauterine growthrestricted pregnancies. J. Clin. Endocrinol. Metab., 2007, 92(6), 2256-2263.
64. Ortega-Senovilla, H.; Alvino, G.; Taricco, E.; Cetin, I.; Herrera, E. Enhanced circulating retinol and non-esterified fatty acids in pregnancies complicated with intrauterine growth restriction. Clin. Sci. (Lond), 2010, 118(5), 351-358.
65. Napoli, J. L. Biochemical pathways of retinoid transport, metabolism, and signal transduction. Clin. Immunol. Immunopathol., 1996, 80(3 Pt 2), S52-S62.
66. Sethi, J. K.; Vidal-Puig, A. J. Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J. Lipid Res., 2007, 48(6), 1253-1262.
67. Poulos, S. P.; Hausman, D. B.; Hausman, G. J. The development and endocrine functions of adipose tissue. Mol. Cell Endocrinol., 2010, 323(1), 20-34.
68. Smith, A. J.; Thompson, B. R.; Sanders, M. A.; Bernlohr, D. A. Interaction of the adipocyte fatty acid-binding protein with the hormone-sensitive lipase: Regulation by fatty acids and phosphorylation. J. Biol. Chem., 2007, 282(44), 32424-32432.
69. Xu, A.; Wang, Y.; Xu, J. Y.; Stejskal, D.; Tam, S.; Zhang, J.; Wat, N. M.; Wong, W. K.; Lam, K. S. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin. Chem., 2006, 52(3), 405-413.
70. Tso, A. W.; Xu, A.; Sham, P. C.; Wat, N. M.; Wang, Y.; Fong, C. H.; Cheung, B. M.; Janus, E. D.; Lam, K. S. Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabet. Care, 2007, 30(10), 2667-2672.
71. Masuzaki, H.; Ogawa, Y.; Sagawa, N.; Hosoda, K.; Matsumoto, T.; Mise, H.; Nishimura, H.; Yoshimasa, Y.; Tanaka, I.; Mori, T.; Nakao, K. Nonadipose tissue production of leptin: leptin as a novel placentaderived hormone in humans. Nat. Med., 1997, 3(9), 1029-1033.
72. Hartmann, B. W.; Wagenbichler, P.; Soregi, G. Maternal and umbilical-cord serum leptin concentrations in normal, full-term pregnancies. N. Engl. J. Med., 1997, 337(12), 863.
73. Aizawa-Abe, M.; Ogawa, Y.; Masuzaki, H.; Ebihara, K.; Satoh, N.; Iwai, H.; Matsuoka, N.; Hayashi, T.; Hosoda, K.; Inoue, G.; Yoshimasa, Y.; Nakao, K. Pathophysiological role of leptin in obesity-related hypertension. J. Clin. Invest., 2000, 105(9), 1243-1252.
74. Okereke, N. C.; Uvena-Celebrezze, J.; Hutson-Presley, L.; Amini, S. B.; Catalano, P. M. The effect of gender and gestational diabetes mellitus on cord leptin concentration. Am. J. Obstet. Gynecol., 2002, 187(3), 798-803.
75. Gross, G. A.; Solenberger, T.; Philpott, T.; Holcomb, W. L., Jr.; Landt, M. Plasma leptin concentrations in newborns of diabetic and nondiabetic mothers. Am. J. Perinatol., 1998, 15(4), 243-247.
76. Lepercq, J.; Cauzac, M.; Lahlou, N.; Timsit, J.; Girard, J.; Auwerx, J.; Hauguel-de Mouzon, S. Overexpression of placental leptin in diabetic pregnancy: a critical role for insulin. Diabetes, 1998, 47(5), 847-850.
77. Maffei, M.; Volpe, L.; Di Cianni, G.; Bertacca, A.; Ferdeghini, M.; Murru, S.; Teti, G.; Casadidio, I.; Cecchetti, P.; Navalesi, R.; Benzi, L. Plasma leptin levels in newborns from normal and diabetic mothers. Horm. Metab. Res., 1998, 30(9), 575-580.
78. Marchini, G.; Fried, G.; Ostlund, E.; Hagenas, L. Plasma leptin in infants: relations to birth weight and weight loss. Pediatrics, 1998, 101(3 Pt 1), 429-432.
79. Wolf, H. J.; Ebenbichler, C. F.; Huter, O.; Bodner, J.; Lechleitner, M.; Foger, B.; Patsch, J. R.; Desoye, G. Fetal leptin and insulin levels only correlate inlarge-for-gestational age infants. Eur. J. Endocrinol., 2000, 142(6), 623-629.
80. Graham, T. E.; Yang, Q.; Bluher, M.; Hammarstedt, A.; Ciaraldi, T. P.; Henry, R. R.; Wason, C. J.; Oberbach, A.; Jansson, P. A.; Smith, U.; Kahn, B. B. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N. Engl. J. Med., 2006, 354(24), 2552-2563.
81. Johansson, S.; Gustafson, A. L.; Donovan, M.; Eriksson, U.; Dencker, L. Retinoid binding proteins-expression patterns in the human placenta. Placenta, 1999, 20(5-6), 459-465.
82. Choi, S. H.; Kwak, S. H.; Youn, B. S.; Lim, S.; Park, Y. J.; Lee, H.; Lee, N.; Cho, Y. M.; Lee, H. K.; Kim, Y. B.; Park, K. S.; Jang, H. C. High plasma retinol binding protein-4 and low plasma adiponectin concentrations are associated with severity of glucose intolerance in women with previous gestational diabetes mellitus. J. Clin. Endocrinol. Metab., 2008, 93(8), 3142-3148.
83. Ukkola, O.; Santaniemi, M. Adiponectin: a link between excess adiposity and associated comorbidities? J. Mol. Med., 2002, 80(11), 696-702.
84. Ategbo, J. M.; Grissa, O.; Yessoufou, A.; Hichami, A.; Dramane, K. L.; Moutairou, K.; Miled, A.; Grissa, A.; Jerbi, M.; Tabka, Z.; Khan, N. A. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J. Clin. Endocrinol. Metab., 2006, 91(10), 4137-4143.
85. Chen, J.; Tan, B.; Karteris, E.; Zervou, S.; Digby, J.; Hillhouse, E. W.; Vatish, M.; Randeva, H. S. Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines. Diabetologia, 2006, 49(6), 1292-12302.
86. Corbetta, S.; Bulfamante, G.; Cortelazzi, D.; Barresi, V.; Cetin, I.; Mantovani, G.; Bondioni, S.; Beck-Peccoz, P.; Spada, A. Adiponectin expression in human fetal tissues during mid-and late gestation. J. Clin. Endocrinol. Metab., 2005, 90(4), 2397-2402.
87. Kadowaki, K.; Waguri, M.; Nakanishi, I.; Miyashita, Y.; Nakayama, M.; Suehara, N.; Funahashi, T.; Shimomura, I.; Fujita, T. Adiponectin concentration in umbilical cord serum is positively associated with the weight ratio of fetus to placenta. J. Clin. Endocrinol. Metab., 2006, 91(12), 5090-5094.
88. Ortega-Senovilla, H.; Alvino, G.; Taricco, E.; Cetin, I.; Herrera, E. Gestational diabetes mellitus upsets the proportion of fatty acids in umbilical arterial but not venous plasma. Diabet. Care, 2009, 32(1), 120-122.
89. Jansson, T.; Cetin, I.; Powell, T. L.; Desoye, G.; Radaelli, T.; Ericsson, A.; Sibley, C. P. Placental transport and metabolism in fetal overgrowth: a workshop report. Placenta, 2006, 27(Suppl A), S109-113.
90. Bonet, B.; Brunzell, J. D.; Gown, A. M.; Knopp, R. H. Metabolism of very-low-density lipoprotein triglyceride by human placental cells: the role of lipoprotein lipase. Metabolism, 1992, 41(6), 596-603.
91. Waterman, I. J.; Emmison, N.; Dutta-Roy, A. K. Characterisation of triacylglycerol hydrolase activities in human placenta. Biochim. Biophys. Acta, 1998, 1394(2-3), 169-176.
92. Lasuncion, M. A.; Herrera, E. "In Vitro" utilization of labelled esterified fatty acids and glyceride glycerol from triglyceride-rich lipoproteins in rat adipose tissue. Horm. Metab. Res., 1981, 13(6), 335-339.
93. Magnusson-Olsson, A. L.; Hamark, B.; Ericsson, A.; Wennergren, M.; Jansson, T.; Powell, T. L. Gestational and hormonal regulation of human placental lipoprotein lipase. J. Lipid Res., 2006, 47(11), 2551-2561.
94. Magnusson, A. L.; Waterman, I. J.; Wennergren, M.; Jansson, T.; Powell, T. L. Triglyceride hydrolase activities and expression of fatty acid binding proteins in the human placenta in pregnancies complicated by intrauterine growth restriction and diabetes. J. Clin. Endocrinol. Metab., 2004, 89(9), 4607-4614.
95. Petersen, S.; Gotfredsen, A.; Knudsen, F. U. Lean body mass in small for gestational age and appropriate for gestational age infants. J. Pediatr., 1988, 113(5), 886-889.
96. Lindegaard, M. L.; Damm, P.; Mathiesen, E. R.; Nielsen, L. B. Placental triglyceride accumulation in maternal type 1 diabetes is associated with increased lipase gene expression. J. Lipid Res., 2006, 47(11), 2581-2588.
97. Miida, T.; Hirayama, S. Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events. Curr. Opin. Lipidol., 2010, 21(1), 70-75.
98. Hato, T.; Tabata, M.; Oike, Y. The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends Cardiovasc. Med., 2008, 18(1), 6-14.
99. Kersten, S. Regulation of lipid metabolism via angiopoietin-like proteins. Biochem. Soc. Trans., 2005, 33(Pt 5), 1059-1062.
100. Romeo, S.; Yin, W.; Kozlitina, J.; Pennacchio, L. A.; Boerwinkle, E.; Hobbs, H. H.; Cohen, J. C. Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J. Clin. Invest., 2009, 119(1), 70-79.
101. Shan, L.; Yu, X. C.; Liu, Z.; Hu, Y.; Sturgis, L. T.; Miranda, M. L.; Liu, Q. The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms. J. Biol. Chem., 2009, 284(3), 1419-1424.
102. Sukonina, V.; Lookene, A.; Olivecrona, T.; Olivecrona, G. Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc. Natl. Acad. Sci. U. S. A, 2006, 103(46), 17450-17455.